Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To Consider and Approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories Limited has informed BSE about a Board of Directors meeting scheduled for Friday, 14 November 2025, at its corporate office in Gachibowli, Hyderabad. The main agenda is to consider and approve the unaudited standalone financial results for the quarter and half year ended 30 September 2025, along with the auditors' Limited Review Report. The company may also discuss any other matter permitted by the Chair. The trading window for designated persons and their immediate relatives has been closed from 1 October 2025 until 48 hours after the board meeting concludes, in line with insider trading regulations.
This is a routine pre-results intimation. Investors should watch for the Q2/H1 FY26 earnings announcement after 14 November 2025, which could move the stock. The closed trading window signals that results are likely material and insiders are restricted from trading until they are made public.